Annuity Atlas
Reviews

Product review · Athene

Athene AccuMax 7 review

Athene AccuMax 7 is the longer-duration sibling of AccuMax 5, offering the same strategy charge model with improved crediting terms across the board. Its biggest strength is the combination of uncapped strategies, participation rates up to 375% on volatility-controlled indices, a 10.00% S&P 500 cap, and a 5.05% fixed account — all with no MVA. Its biggest weakness is the same as AccuMax 5: strategy charges are deducted annually on enhanced strategies whether the index gains or not, and the 7-year surrender period requires a longer commitment.

Our rating

4.2★ / 5
Strong Option
Buyers who want a 7-year accumulation FIA with strategy charges that enable higher crediting potential from a top-rated carrier
Get my free quote
Surrender
7 years
Issue ages
0-85
MGSV
87.5%
Free withdrawal
10% yr 1+
01

Why it earned this rating

Our assessment

Extends the AccuMax strategy charge design to a 7-year timeline, potentially offering better crediting terms than the 5-year version. The top-tier carrier backing and competitive design make it a strong mid-duration accumulation option.

02

The short version

If someone looked at AccuMax 5 and wished the crediting terms were a little better, AccuMax 7 is the answer. The improvements are real but incremental — a half-point higher cap, a quarter-point tighter spread, 10 more percentage points of S&P 500 participation, and a modestly higher fixed rate. Whether those improvements justify two additional years of commitment depends on the buyer's time horizon and confidence in the strategy charge model. For someone who is already planning to hold for 7 years, this is the stronger choice.

03

Key facts

Product Type
Fixed Indexed Annuity with Strategy Charges
Product Focus
Medium-Term Accumulation
Issue Ages
0-85
Minimum Premium
$25,000
Maximum Premium
$1,000,000
Income Rider
Not available
Free Withdrawal Access
10% of account value per year
Surrender Schedule
8% / 8% / 7% / 6% / 5% / 4% / 3% / 0%
MVA
No
Death Benefit
Greater of account value or MGCV
Waivers
Confinement and Terminal Illness
Bailout Provision
Yes
Strategy Presets
Conservative, Balanced, Growth
State Availability
49 states excluding New York
04

The full review

Is Athene AccuMax 7 a Good Annuity?

Yes, for the right buyer. This is a strong accumulation FIA for someone who wants enhanced crediting potential through the strategy charge model and has a 7-year time horizon. It offers better terms than AccuMax 5 across every strategy. It is less appealing for someone who cannot commit to 7 years, wants a simple no-charge product, or needs income guarantees.

Why Someone Would Buy This Annuity

The main reason to buy AccuMax 7 is to get better accumulation terms than the 5-year version while staying within the same product family and strategy charge framework. The S&P 500 cap is 10.00% versus 9.50%. The uncapped S&P 500 spread strategy charges 1.25% versus 1.50%, which means you keep more of the index return. The S&P 500 participation strategy offers 210% versus 200%, with a slightly lower strategy charge of 1.75% versus 2.00%. The volatility-controlled index options push participation rates to 210-375%, compared to 200-350% on the 5-year version. And the fixed account pays 5.05% versus 4.80%. Every crediting option is modestly better, which is the standard reward for accepting a longer surrender period.

Who This Annuity Is Best For

I think AccuMax 7 is best for someone who has a clear 7-year time horizon and wants to maximize accumulation potential within a principal-protected structure. It is a natural fit for a buyer who has already decided they are comfortable with the strategy charge model and wants the best possible terms within that framework. It also works for someone who is comparing 7-year FIAs across carriers and wants uncapped strategies that most traditional products do not offer. It is not a good fit for someone who might need their money before 7 years, who is uncomfortable with the complexity of strategy charges, or who wants income planning features.

What You're Really Buying Here

You are buying a 7-year insurance contract that uses the same strategy charge model as AccuMax 5 but with improved crediting terms across every option. Your principal is protected from market losses. The enhanced strategies — uncapped S&P 500, high-participation volatility-controlled indices — charge annual fees of 0.50% to 2.00% in exchange for removing caps and boosting participation rates. The base strategies (S&P 500 cap and fixed account) carry no charges. The extra two years of commitment compared to AccuMax 5 is what allows Athene to offer the improved terms.

How the Core Feature Works

AccuMax 7 offers the same two-tier crediting structure as AccuMax 5. The base tier includes a standard S&P 500 annual point-to-point with a 10.00% cap and a fixed account at 5.05%, both with no strategy charge. These are straightforward — your upside is capped, but there is no cost.

The enhanced tier is where the product differentiates itself. The S&P 500 point-to-point with spread strategy has no cap and charges a 1.25% spread, meaning if the S&P 500 returns 12%, you are credited 10.75%. The S&P 500 with 210% participation charges 1.75% annually and is uncapped — a 10% index return becomes 21% before the charge, or roughly 19.25% net. The BNP Paribas Multi Asset Diversified 5 index offers 220% participation, and other volatility-controlled indices reach as high as 375% participation with corresponding strategy charges. The strategy presets (Conservative, Balanced, Growth) provide pre-built allocations for buyers who prefer a guided approach.

The improvement over AccuMax 5 is consistent but incremental. The tighter spread on the uncapped S&P 500 strategy (1.25% vs. 1.50%) and the lower strategy charge on the 210% participation option (1.75% vs. 2.00%) mean you keep a larger share of the upside. Over 7 years, those differences compound.

Why the Secondary Feature Matters

Principal protection is the safety net that makes the strategy charge model viable. In any given year, an enhanced strategy can produce a net loss to your account value if the index returns less than the strategy charge. But over the full 7-year contract term, the guaranteed minimum contract value ensures your principal is protected. This means the worst-case outcome at maturity is getting your money back — not a loss of principal.

This matters because the strategy charge model asks buyers to accept short-term volatility in their account value in exchange for higher long-term upside potential. Without the principal protection guarantee, that tradeoff would be much harder to stomach. The no-MVA structure reinforces this — if you do need to access money early, the surrender charge is the only cost, with no additional market value adjustment layered on top.

Liquidity and Surrender Schedule

AccuMax 7 allows free withdrawals of up to 10% of account value per year. Amounts above that are subject to the surrender schedule. There is no market value adjustment.

Surrender schedule: **8% / 8% / 7% / 6% / 5% / 4% / 3% / 0%**

The schedule starts at 8% for the first two years, then declines steadily to 3% in year 7 before dropping to zero. The decline is smooth and predictable. Confinement and terminal illness waivers provide additional access in qualifying situations. The bailout provision offers a way out if crediting terms deteriorate significantly. The no-MVA structure is a genuine advantage — many 7-year FIAs include an MVA that can add unpredictable cost to early withdrawals.

Fees and Tradeoffs

There are no annual product fees on the base contract. Strategy charges of 0.50% to 2.00% apply only to enhanced strategies. The base S&P 500 cap strategy and fixed account carry no charges.

The core tradeoff is identical to AccuMax 5: strategy charges are deducted annually regardless of index performance. The difference is that AccuMax 7's charges are slightly lower on comparable strategies (1.75% vs. 2.00% on the S&P 500 participation strategy, 1.25% vs. 1.50% on the spread strategy), which means the breakeven point — the index return needed to offset the charge — is lower. Over a 7-year period, this gives AccuMax 7 a modest mathematical edge, but only if you hold through the full term. The volatility-controlled indices, while offering very high participation rates, have their own embedded index costs that affect real-world performance independently of the strategy charges.

Product snapshot
FeatureDetails
Product typeFixed indexed annuity with strategy charges
Product focusMedium-term accumulation (7-year)
Issue ages0-85
Minimum premium$25,000
Maximum premium$1,000,000
Income riderNot available
Free withdrawals10% of account value per year
Surrender schedule8% / 8% / 7% / 6% / 5% / 4% / 3% / 0%
Market value adjustmentNo
MGSVYes, principal protected at maturity
Death benefitGreater of account value or MGCV
Crediting optionsS&P 500 cap 10.00%, S&P 500 PTP spread 1.25% (uncapped), S&P 500 210% participation (uncapped, 1.75% charge), BNP MAD 5 220%, various vol-controlled indices 210-375% participation, fixed 5.05%
Strategy charges0.50% to 2.00% annually on enhanced strategies
WaiversConfinement and Terminal Illness
Bailout provisionYes
Annuitization optionsAvailable
Carrier snapshot

Athene AccuMax 7 is issued by Athene Annuity and Life Company, headquartered in West Des Moines, Iowa, and founded in 1909. Athene is a subsidiary of Apollo Global Management and holds $363.3 billion in total GAAP assets. The company carries ratings of A+ from A.M. Best, A+ from Fitch, A+ from S&P, and A1 from Moody's, with a Comdex score of 88. Athene is one of the largest fixed annuity issuers in the United States and issues products in 49 states (excluding New York) and the District of Columbia.

Final take

AccuMax 7 is the version of the AccuMax lineup that offers the best crediting terms, and for someone with a 7-year time horizon, those improved terms are worth the longer commitment. The tighter spreads, higher participation rates, and better fixed rate all compound over time. The no-MVA structure and 10% annual free withdrawal keep the liquidity profile reasonable for a 7-year product.

The main question for any buyer is whether to choose AccuMax 5 or AccuMax 7. If you are confident in a 7-year hold, AccuMax 7 is the better deal on crediting terms. If you value the shorter exit and are willing to accept modestly lower rates, AccuMax 5 makes more sense. Both are strong options in their respective peer groups — the difference comes down to time horizon and how much the incremental improvement in crediting terms matters to you.

Ready to see how it stacks up?

  • Income, fees & ratings compared
  • Across every reviewed product
  • 100% free. No pressure.
Compare annuities